Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Subjects ≥ 70 Years
This study has been completed.
Study NCT00561080   Information provided by Sanofi Pasteur MSD

First Received on November 19, 2007.   Last Updated on September 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prevention of : Herpes-Zoster
Additional conditions recognized in this trial
Herpes Zoster
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
Virus Diseases
Interventions listed in this trial
Zostavax
Sponsors listed in this trial
Sanofi Pasteur MSD


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services